CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-18 | Sheena Jonathan Director | Sale 10b5-1 | −430 | $146.78 | $63K | 41,782 |
| 2025-03-18 | Sheena Jonathan Director | Sale 10b5-1 | −1,010 | $145.21 | $147K | 42,272 |
| 2025-03-18 | Sheena Jonathan Director | Sale 10b5-1 | −490 | $146.78 | $72K | 41,782 |
| 2025-03-17 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −6,702 | $146.03 | $979K | 203,354 |
| 2025-03-17 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −790 | $146.03 | $115K | 71,871 |
| 2025-03-17 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −2 | $149.58 | $299 | 71,869 |
| 2025-03-17 | Sheena Jonathan Director | Sale 10b5-1 | −181 | $146.03 | $26K | 261,019 |
| 2025-03-17 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −1,124 | $146.03 | $164K | 2,364,291 |
| 2025-03-17 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −3 | $149.58 | $449 | 2,364,288 |
| 2025-03-17 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −926 | $146.03 | $135K | 224,187 |
| 2025-03-17 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −2 | $149.74 | $299 | 224,185 |
| 2025-03-17 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,023 | $146.03 | $149K | 144,785 |
| 2025-03-17 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −3 | $149.74 | $449 | 144,782 |
| 2025-03-17 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −793 | $146.03 | $116K | 157,291 |
| 2025-03-17 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −2 | $149.58 | $299 | 157,289 |
| 2025-03-14 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale | −1,000 | $145.37 | $145K | 2,414,415 |
| 2025-03-14 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale | −4,798 | $146.58 | $703K | 2,409,617 |
| 2025-03-14 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale | −29,967 | $147.64 | $4.4M | 2,379,650 |
| 2025-03-14 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale | −13,935 | $148.38 | $2.1M | 2,365,715 |
| 2025-03-14 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale | −300 | $149.00 | $45K | 2,365,415 |
Page 52 of 55 · 1,093 trades